Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

University of Southern California provides funding as a member of The Conversation US. Three days before his presidential inauguration, Donald Trump launched a meme coin, a type of cryptocurrency ...

The recent launch of a meme coin by President Trump has reinvigorated the debate over meme coins. Investing in blockchains like Solana is one way to get exposure to the meme coin phenomenon ...

It's easy to dismiss meme coins. The conventional thinking has always been that you should steer clear of them. They are too risky and too speculative, and it's nearly impossible to make money ...

Beyoncé’s stunned reaction at the 2025 Grammys became an instant meme. The hitmaker, 43, couldn’t believe it when Taylor Swift announced “Cowboy Carter” had won best country album at the ...

Benzinga's top picks for the best meme coins for this month include Dogecoin, Shiba Inu, Pepe, Baby Doge Coin and Floki Inu. You can buy these top meme coins from crypto exchanges like eToro ...

In the series, recruiters find people who are hard on their luck and draw them in to compete in a show full of children’s games. They find out that the novel concept and cash prize come with a ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA ...

Zepbound is an injectable prescription medication created to help adults with obesity and weight-related problems, including obstructive sleep apnea. OSA causes airway collapses during sleep and ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.